Educational Areas/Call for Grants


Areas of Educational Interest Available Funding Call for Grants
Cardiovascular
Acute Coronary Syndrome  
High Risk Prior Myocardial Infarction  
Hypertriglyceridemia  
Heart Failure – SGLT2 Inhibition
 
Secondary Prevention Acute Ischemic Stroke  
Endocrinology/Metabolic
Type 1 Diabetes  
Type 2 Diabetes  
Type 2 Diabetes – Heart Failure
 
Type 2 Diabetes – Chronic Kidney Disease
 
INFECTIONS & VACCINES
SARS-CoV-2 Monoclonal Antibody  
SARS-CoV-2 Vaccine  
Nephrology
Chronic Kidney Disease - Anemia  
Chronic Kidney Disease – SGLT2 Inhibition
 
Hyperkalemia  
Oncology
Advanced Breast Cancer
BRCA  
Non-BRCA  
DNA Damage Response  
PARP Inhibition  
HER2+ CGA_ONC_HER2_Breast_2101_Pathology
Metastatic HR+  
Gastric Cancer
Gastric Cancer - HER2+  
Hematology
CLL (Chronic Lymphocytic Leukemia)  
MCL (Mantle Cell Lymphoma)  
HCL (Hairy Cell Leukemia)  
WM (Waldenstrom Macroglobulinemia)  
Immuno-Oncology
Bladder  
imAE Management  
Extensive-Stage SCLC
 
Non-Metastatic NSCLC  
iHCC (intermediate stage Hepatocellular Carcinoma)  
uHCC (unresectable Hepatocellular Carcinoma)  
Biliary Track Cancer (BTC)  
IO Diagnostics - Multidisciplinary Team  
IO Lung Diagnostics - Staging  
Neurofibromatosis
Neurofibromatosis Type 1  
Plexiform Neurofibromas  
Non-Small Cell Lung Cancer
EGFR Diagnostics & Plasma Testing  
EGFRm+ NSCLC  
HER2+ NSCLC  
Ovarian Cancer
BRCA  
Non-BRCA  
PARP Inhibition  
DNA Damage Response  
Pancreatic Cancer
BRCA  
DNA Damage Response  
PARP Inhibition  
Prostate Cancer (mCRPC)
DNA Damage Response  
Homologus Recombination Repair  
PARP Inhibition  
Respiratory
CRSwNP (EX-US only)  
COPD


CGA Respiratory COPD 2021 Best Practice Sharing

CGA Respiratory COPD Grand Rounds 2021 02

CGA Respiratory COPD Grand Rounds 2021 03

 

Chronic Cough (EX-US only)  
Asthma (EX-US only)  
Severe Asthma
(US only, accepting applications with 2022 start date)
CGA Respiratory AAAAI 2022 Severe Asthma
CGA Respiratory ATS 2022 Severe Asthma
Rheumatology/Immunology/Autoimmune
Systemic Lupus Erythematosus

CGA_Rheumatology_SLE_State Chapter Meetings 2021 01

CGA_Rheumatology_SLE_General_2021_02

R & D Discovery
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities.